Content related to Why Is it Important to Choose a Pediatric Research Hospital With Access to Clinical Trials?

Facing a new diagnosis? A pediatric oncologist explains what the care journey looks like for acute lymphoblastic leukemia, the most common form of childhood cancer.

A statistical analysis of the largest study cohort to date sheds light on improvements—and gaps—in post-relapse treatment for Acute Lymphoblastic Leukemia.

Five important questions that parents should ask about participating in a cancer clinical trial.

Historically, middle- and higher-income White families and individuals of European ancestry have been the vast majority of participants in clinical trials

The ambitions of pediatric researchers are global in scale: Beyond patients at their own hospital, they look to shape national and international standards for pediatric care.

Four investigators share their research—and how the USC/CHLA facility will help bring novel cell therapies to clinical trials faster.

Chimeric antigen receptor (CAR) T-cell therapy uses a person’s own immune cells that have been modified to recognize and attack cancer cells.

Dealing with childhood cancer is difficult. Selecting a pediatric oncologist shouldn’t be. Find out what to look for when choosing your child’s care team.

Clinical trials bring new research to kids and adults. Why should adults and kids take part in clinical trials? Because everyone can benefit.